Business of Cannabis & Releaf go all Trump word salad on this advertorial piece
Interested to see how their model works if government has just said we’re restricting online sales
The European medical cannabis market has been transformed over the last five years, evolving from a fringe, start-up-dominated industry into a thriving international ecosystem breaking into the forefront of the political and social zeitgeist.
Nowhere is this more apparent than in the UK and Germany. Both markets are regional frontrunners, and both are at the top of the list for any operator chasing expansion. Yet, both are on very different paths.
While the UK has seen consistent but steady growth, Germany has seen an explosion in patients, products, and new operators, many of whom have ridden this wave all the way to the bank.
As the conversation turns to German consolidation and retraction, UK medical cannabis clinic Releaf sees an unmissable opportunity.
Tim Kirby, Releaf’s CEO, told Business of Cannabis: “A lot of operators in Germany are drinking their own champagne. It’s very easy to feel successful when there’s huge demand, but that doesn’t mean you’re good at it. If the wind is blowing hard enough, even turkeys can fly.
“We forensically understand the competitive landscape in Germany, the marketing setups of incumbent providers, their SEO authority structures, and quite frankly, they resemble school projects compared to what we’ve built, and that’s not my opinion, I say it objectively not out of any arrogance, its a datapoint, look at how Releaf dominates the digital landscape in the UK.”
Success does not mean world-class execution
Releaf is a relative newcomer in the UK medical cannabis market, having officially ‘opened its virtual doors’ on February 01, 2024.
Despite this, over the last 18 months, the tech-focused clinic has rapidly evolved into one of the country’s largest players, and is now the fastest-growing clinic in the market, serving over 4,000 new patients a month.
Furthermore, it says recruitment is in flight to grow to 10,000 new patients a month over the next six months, while growing the current doctor number from 43 to close to 100.
“In the UK, we had 1.2 million unique visitors to our website in July and August. Our nearest competitor had less than half that, despite spending more than €300,000 a month on marketing. We spent €25,000. The difference is our digital ecosystem,” Kirby explained.
More if you can bear it here.
